Back to Search
Start Over
Glitazones in the treatment of cardiovascular risk factors.
- Source :
-
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2007 Nov; Vol. 21 Suppl 2, pp. 7-13. - Publication Year :
- 2007
-
Abstract
- This review focuses on the recent advances on the role of the nuclear receptor peroxisome proliferator-activated receptor gamma in the modulation of vascular lipid homeostasis and the inflammatory response and the potential role of these activities in the modulation of metabolic and cardiovascular disease.
- Subjects :
- Atherosclerosis etiology
Atherosclerosis prevention & control
Cardiovascular Diseases metabolism
Cholesterol metabolism
Clinical Trials as Topic
Humans
Macrophages drug effects
Macrophages metabolism
PPAR gamma agonists
PPAR gamma metabolism
Risk Factors
Thiazolidinediones adverse effects
Thiazolidinediones pharmacology
Cardiovascular Diseases prevention & control
Thiazolidinediones therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0767-3981
- Volume :
- 21 Suppl 2
- Database :
- MEDLINE
- Journal :
- Fundamental & clinical pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 18001313
- Full Text :
- https://doi.org/10.1111/j.1472-8206.2007.00531.x